Between the two seas

Start date: 01/10/2018
End date: 31/03/2022

Funding
Total project budget: €6,843,950.50
Amount of ERDF funding: €4,106,370.03
Funding rate: 60%

Aim
3DMed aims to improve the affordability and large-scale accessibility of medical treatment using 3D printed devices. Top universities and innovative companies in the Netherlands, Belgium, France and the UK join forces in an unprecedented exercise to explore the full potential of the 3D printing technology for advanced medical care.

Expected results

• Streamlined care by integrating diagnosis, design and manufacturing of 3D printed medical devices with post-operative evaluation into a validated and widely accessible software platform. This will enable reduction of lead times from 6-8 weeks currently to 6-8 days by 2021 and to 24 hours by 2023.
• Personalised medical devices (prostheses, implants and orthoses) designed using the images acquired for individual patients. Using the integrated 3D printing technology to manufacture these customised devices will lead to reductions in cost by as much as 90%. The costs for the medical treatments will thereby be decreased by as much as 30%.
• Complex shapes and miniaturised geometries for implants and surgical instruments, as well as functionalised medical devices to enhance treatment effectiveness and speed up post-treatment recovery.

Lead partner: Technische Universiteit Delft

Project Partners

• Stichting Materials innovation institute
• Ghent University
• Association pour la Recherche et le Développement des Méthodes et Processus Industriels
• EXO-L B.V.
• Dutch Ophthalmic Research Center (International) B.V.
• Meridian Technique Limited
• Amber Implants B.V.
• University of Oxford
• Oxford MESTAR Limited
• 3D LifePrints
• EURASANTÉ
• University of Lille

Observer Partners

• Reinier de Graaf Groep
• AZZENO/Cosmipolis Clinic
• University Medical Center Utrecht
• Department of Plastic Surgery, Oxford University Hospitals NHS Foundation Trust
• Leiden University Medical Center
• CADskills BVBA
• Nelson Labs Europe N.V.
• DEAM BV
• Dassault Systèmes
• Medtronic
• LATTICE MEDICAL

Contact us: Florence Siepmann - florence.siepmann[at]univ-lille[point]fr

Website

Start date: 01/01/2017
End date: 30/06/2021

Funding
Total project budget: modification under consideration
Amount of ERDF funding: request for modification under consideration
Funding rate: 60%

Project aims

The project involves the use of gas hydrates to capture and store CO2 and CO from combustion products in the industrial steelmaking sector. Hydrates are solid crystalline structures made up of cages of water molecules (clathrates), which make it possible to take advantage of the selectivity of gas enclathration in this structure to preferentially capture one gas (CO2 but also CO) over other gases (typically N2). Compared with ‘amine’ technology, which is currently used at flue gas or coal-fired power stations, this concept aims to halve operating costs. Additionally, from an ecological perspective, these compounds are more interesting than the amine chemical process.

Expected results

Several results were obtained.

We first carried out successful experiments and produced results on the performance parameters for capturing CO2 from flue gas analogue using the Hydrtaes ‘HBSP’ process. Typically, a flue gas analogue containing 10% CO2 + 90% N2 has been processed by HBSP and shown to selectively trap up to 47% of CO2 in a single step, which can be competitive with regard to existing technology when used alone or as part of a hybrid configuration (for more details see Rodriguez et al., Chem. Eng. J. 382, 122867, 2020).

At the same time, we have been conducting experiments to propose a new way of using the captured CO2. Although not foreseen at the start of the project in 2017, this new value-adding avenue specifically concerns the evaluation of value-adding. This new route involves a chemical stimulation method, whereby captured CO2 gas is injected into methane-containing natural gas hydrates in hydrated sediments. The underlying principle of this technique is based on the infusion of CH4 clathrate hydrates with captured CO2 gas (or flue gas), resulting in the extraction of CH4 from the clathrate hydrate structures and the subsequent capture and storage of CO2 in the same structures. From the perspective of the global carbon cycle, this CH4-CO2 gas exchange process appears particularly favourable and shows great potential for sustainable development with industrial considerations. Details of these results can be found in Le et al., Applied Energy, 280, 115843, (2020).

Our project is now focusing on the separation of the CO/N2 mixture, which is a key element of the project, since it is the extraction line for utilising the CO. The expected results concern the measurement of performance parameters for the hydrate structure.

In parallel, a techno-economic assessment of clathrate-based CO2-CO separation in a conceptual design case study will be carried out in collaboration with partner Dow Chemical.

Partners

• Arcelor Mittal (Belgium)
• Dow Chemical (Netherlands)
• Lanzatech (UK)
• POMOV (Belgium)
• ISPT (Netherlands)

Contact: Bertrand Chazallon - bertrand.chazallon[at]univ-lille[point]fr

Website

Start date: 01/04/2017
End date: 31/03/2023

Funding
Total budget: 12,573,153.15 euros
Amount of ERDF funding: 7,543,891.89 euros
Funding rate: 60%

Aims
The CASCADE project proposes financially sustainable care pathways that would enable elderly people with or without dementia to remain in their own homes for as long as possible. These care pathways will be adaptable to the cultural and social differences that exist in European countries.

Expected results

The CASCADE project aims to create open facilities. These facilities will enable elderly people with or without dementia to maintain their independence and integrate into the local community.

Partners

• East Kent Hospitals University NHS Foundation Trust
• Medway Community Healthcare
• Canterbury Christ Church University
• Emmaus
• Holy Hart
• ZorgSaam
• Expertisecentrum Dementie Vlaanderen
• HZ University of Applied Sciences

Contact:

Health and Europe Centre
Kent & Medway NHS and Social Care Partnership Trust
Hermitage Lane
Maidstone, Kent ME16 9PH
Tel: + 44 (0)1622 427213
www.healthandeuropecentre.nhs.uk

Website

Start date: 01/01/2018
End date: 30/09/2022

Funding
Total project budget: €3,800,000
Amount of ERDF funding: €2,280,000
Funding rate: 60%

Aims
The CoBra project aims to improve the quality of diagnosis and treatment of localised cancers by developing a new prototype medical robot for MRI-guided brachytherapy and biopsy.

This enables adaptive tumour monitoring and real-time dose control to achieve the overall goal of improving patient quality of life and reducing cancer mortality.

Expected results

• Technology – development of a new prototype medical robot for MRI-guided diagnosis and treatment of cancers by brachytherapy and biopsy.
• Training – launch of a training programme for practitioners and physicists based in the ‘2 Seas’ region in MRI brachytherapy and robotic biopsy.
• Socio-economic study – drawing up a map showing how targeted cancers are dispersed in the ‘2 Seas’ region. This makes it possible to estimate the optimal placement of the developed concept in the ‘2 Seas’ region based on the concentration of patients.
• Networking – developing a network of SMEs and start-ups for technology transfer of the new concept.

Lead partner: University of Lille

Partners

• Centre Oscar Lambret (France, Lille)
• Eurasanté (France, Lille)
• DEMCON (Netherlands, Delft)
• Delft University of Technology (Netherlands, Delft)
• Portsmouth Hospitals University NHS Trust (United Kingdom, Portsmouth)
• University of Portsmouth (United Kingdom, Portsmouth)
• Société d'Accélération du Transfert de Technologie - SATT Nord (France, Lille)
• Oncovet (France, Lille)

Observer partners

• Philips MR Clinical Science (Netherlands)
• Wessex Academic Health Science Network AHSN (United Kingdom)
• Elekta (Netherlands)
• Eckert & Ziegler BEBIG GmbH (Germany)
• KUKA Deutschland GmbHv
• Institut Faire Faces (France)
• MaRVis Interventional GmbH (Germany)
• Medical Targeting Technologies GmbH MTT (Germany)
• NORAS MRI products GmbH (Germany)
• Therapanacea (France)
• University of Harvard (United States)

Contact: Rochdi Merzouki (Cristal), Scientific Coordinator - contact[at]cobra-2seas[point]eu

Website

Start date: 01/07/2018
End date: 30/06/2022

Funding
Total project budget: €7,184,812
Amount of ERDF funding: €511,950.09
Funding rate: 60%

Aims
CRIStAL dynamic modelling team

• PEM electrolyser system performance and lifetime modelling simulation tool (multiphysics dynamic model and numerical simulation platform for testing electrolyser performance and remaining useful life).
• Report on modelling, simulation and control strategies for direct and indirect conversion processes.

UCCS team

• Design of bifunctional hybrid and composite metal-acid catalysts, optimisation of reaction conditions, optimisation of catalyst stability for metal sintering and coking, testing of commercial catalysts.
• Design of the SEDMES (Sorption-Enhanced-Dimethyl Ether Synthesis) transient operating mode with adsorbent, kinetic modelling, laboratory-scale testing and selection of optimised catalysts for evaluation under industrial conditions.

Expected results
Here are the expected results:

CRIStAL dynamic modelling team

• Development of a graphical Human-Machine Interface (HMI) under Matlab-Simulnk for simulation and supervision of the proton exchange membrane (PEM) electrolyser
  * Generic model (modular design) for behavioural studies that can be adapted to any PEM electrolyser configuration, from laboratory to industrial scale
  * Off-line and on-line supervision (diagnostics) for PEM electrolysers powered by intermittent sources (wind and solar)
  * Estimation of remaining service life (prognosis) for PEM electrolyser (State of the art for PEM electrolyser prognosis).
  * Demonstration of the graphical user interface developed on the pilot-scale multisource PEM electrolysis platform available at the University of Lille (Polytech Lille C008, France)
  * State of the art to identify control strategies for the sorption-enhanced dimethyl ether synthesis (SEDMES) process where hydrogen produced by the electrolyser is used with carbon dioxide to produce dimethyl ether (DME))

UCCS catalysis team

• Design of several series of hybrid and composite catalysts based on copper-zinc-alumina zeolites -SAPO34 and CuPd-ZSM-5 for the direct synthesis of dimethyl ether from_CO2 and hydrogen
• In-depth characterisation of catalysts using physico-chemical techniques (XRD, BET, XPS, FTIR, TEM) to identify the key factors responsible for improving catalytic performance
• Design of a new experimental set-up and procedure for direct transient dimethyl synthesis (sorption-enhanced dimethyl ether synthesis; SEDMES)
• State-of-the-art synthesis of methanol and dimethyl ether from_CO2

Partners

• Netherlands Organisation for Applied Scientific Research (TNO)
• Energy research centre of the Netherlands (ECN)
• Flemish Institute for Technological Research (VITO)
• Technical University Delft (TUD)
• University of Antwerp (UAN)
• University of Exeter (UEX)
• The University of Sheffield (USFD)

Contact:

• Netherlands Organisation for Applied Scientific Research (TNO) coordinator: Martin de Graff - martijn.degraaff[at]tno[point]nl
• Scientific directors at the University of Lille: Belkacem Ould Bouamama (CRISTAL) - belkacem.ouldbouamama@univ-lille.fr / Andrei Khodakov (UCCS) - andrei.khodakov[at]univ-lille[point]fr

Website

Start date: 01/07/2016
End date: 30/06/2021

Funding
Total project budget: €5,960,059.5
Amount of ERDF funding: €1,144,935.96

Aims
The IMODE project aims to accelerate the development of new knowledge and manufacturing processes for the design of sustainable, high-quality, low-cost drugs and medical devices. The IMODE project seeks to strengthen innovation in the ‘2 Seas’ area in order to gain a strategic advantage for new pharmaceutical and medical applications that bridge the current gap between academia and the private sector by collaborating with academic groups and companies conducting integrated transdisciplinary research in materials science, pharmaceuticals and medicine.

Expected results

• Formulation screening platform to accelerate pharmaceutical product development
• New technologies for the synthesis of pharmaceutical co-crystals and salts
• New approaches to nanofabrication of gene delivery systems
• Optimised processes for solid dispersions in patient-specific dosage forms
• Increased understanding of drug delivery from injectable/implantable drugs
• New plant-derived excipients for the controlled release of active pharmaceutical ingredients
• Design of innovative medical devices for the treatment of coronary artery disease

Partners

• University of Lille - coordinator (France)
• University College London (United Kingdom)
• Ghent University (Belgium)
• University of East Anglia (United Kingdom)
• ImaBiotech (France)
• University of Greenwich (United Kingdom)
• G.I.E. Eurasanté (France)
• Ashford and St Peter’s Hospitals NHS Foundation Trust (United Kingdom)
• Cubic Pharmaceuticals Limited (United Kingdom)
• Roquette Frères (France)

Contact: Frédéric Affouard (UMET), scientific coordinator - frederic.affouard[at]univ-lille[point]fr

Website

Start date: 08/02/2018
End date: 31/10/2021

Funding
Total budget: €227,506.60
Amount of ERDF funding: €136,503.96
Funding rate: 60%

Aims

The project is part of a drive to adopt a circular economy in greenhouse horticulture by developing sustainable growing media using natural resources from the agricultural and fishing sectors of the ‘2 Seas’ area.

The solutions we offer meet consumers’ increasingly demanding environmental and health criteria. These requirements concern, firstly, reducing greenhouse gas emissions and, secondly, limiting pesticide residues in horticulture. More specifically, the project’s aims concern:

• Production of biochar and chitin for use as new crop additives to replace chemical fertilisers and pesticides.
• Design of new growing media formulations: peat-free, 100% organic mixes for tomatoes, and reduced-peat mixes (replacing 40% of peat) for strawberries.
• Reuse of used growing media, either through direct reuse or as raw material for biochar and compost.
• Development of gasification technology for biochar production.

Expected results

In the course of this project, sustainable growing media were developed using co-products from the fishing and agricultural sectors. The measures involved:

• Large-scale gasification for biochar production.
• Large-scale production of chitin from shrimp shells. This measure was carried out by partner the University of Lille (UMRT 1158 - BioEcoAgro - Institut Charles Viollette).
• Implementation of in vitro and greenhouse tests to demonstrate the efficacy of the products developed.

Partners

• Flanders Institute for agriculture, fisheries and food (ILVO)
• ECN>TNO
• ADAS
• Agaris
• University of Lille
• NIAB EMR
• University of Portsmouth
• Proefcentrum Hoogstraten
• Cato Engineering

Contact:
Laura Golsteyn: laura.golsteyn@ilvo.vlaanderen.be

Website

Start date: 01/02/2020
End date: 30/03/2023

Funding
Total project budget: €444.216.45
Amount of ERDF funding: €266,529.87
Funding rate: 60%

Aims
The MONUMENT project aims to reduce the burden felt by family carers of people suffering from Alzheimer’s disease or related disorders by providing them with professional and structural support as well as personalised technological solutions.

Three main aims:

• Creating and testing a pilot project based on the Odense centres in Maubeuge
• Testing and co-creating technological solutions
• Providing political bodies with an analysis of the model’s cost-effectiveness

The overall aim is to enable people suffering from these illnesses to remain at home by strengthening caregivers’ ability to adapt and improving their mutual and relational well-being based on the Odense centre model.

An Odense centre is a place where people can get information and advice, and where people with dementia, carers and their families and friends can meet. Several types of activities take place here, including meetings, activities and advice. Support focuses on the human aspect to help prevent isolation among caregivers and the loved ones they care for, and direct them towards existing resources to prevent exhaustion.

The SCALab team aims to:

• Provide methodological and technical support in setting up focus groups with professionals from the regional network and caregivers in order to highlight the needs and expectations of future beneficiaries of the Odense Centre in Maubeuge;
• Make available various types of online or face-to-face support for caregivers who are beneficiaries of the Odense Centre;
• Participate in the design of the international online caregiver support platform and the development of online self-study material to help family caregivers improve their knowledge and skills.

European partners
11 partners from France, Belgium, the Netherlands and the UK.

• Center of Expertise on Dementia Flanders (BE)
• IMEC (BE)
• Norfolk County Council (UK)
• AFEJI (FR)
• University of Lille (FR)
• Eurasanté (FR)
• HZ University of Applied Sciences (NL)
• !DROPS (BE)
• Voluntary Norfolk (UK)
• The National Trust for Places of Historic Interest or Natural Beauty (UK)
• Foundation Odense House Walcheren (NL)

Contact: Emilie Wawrzicny (SCALab): emilie.wawrziczny[at]univ-lille[point]fr

Website

Start date: 01/12/2019
End date: 30/09/2022

Funding
Total project budget: €6,499,430.20
Amount of ERDF funding: €206,394
 

Aims
The aim of this project is to improve territories’ ability to adapt to climate change, and more specifically to the risk of flooding. The project is based on large-scale experiments, which will be carried out on a flood protection dike on the border between Belgium and the Netherlands.

Through the performance and analysis of dyke failure and repair tests, we aim to:

• Improve practical knowledge of flood risk adaptation.
• Establish a shared database and knowledge base on flood risk adaptation.
• Educate and train young water professionals.
• Improve collaboration between the actors involved.

Expected results

• A database on dike response and emergency measures in the event of a dike breach, which can lead to flooding.
• A database on the performance of different techniques for repairing dikes following failure.
• A knowledge base on adapting dikes based on flood risk.
• Training young people in flood risk management techniques and methods.

Partners

• Stichting Toegepast Onderzoek Waterbeheer (STOWA)
• Department of Mobility and Public Works (Flanders Hydraulics Research and the Geotechnical division)
• South West Water (Science and Water Quality Department, Drinking Water Services)
• Environment Agency (Asset Performance and Engineering Flood & Coastal Risk Management)
• Delft University of Technology (Civiele Techniek en Geowetenschappen (CITG))
• Province of Zeeland (Project Leader at the Province of Zeeland)
• Netherlands Defence Academy (NLDA) | Corps of Engineers | Corps of Army Reservists
• Catholic University Leuven (KU Leuven) (KU Leuven R&D, Research Group Coastal and Geotechnical Engineering-Department of Civil Engineering - Bruges Campus)
• ISL Engineering (ISL Lille)
• HZ University Of Applied Sciences (Delta Applied Research Centre Building with Nature and Resilient Deltas)
• Center of Studies, Expertise, Risks, Enviroment, mobility and Spatial Planning (Cerema) (Departement North Picardy)
• Ministry of Infrastructure and Water management (RWS) (Rijkswaterstaat)
• University of Lille - LGCgE

Website

Start date: 14/01/2019
End date: 31/03/2022

Funding
Total project budget: €229,966.60
Amount of ERDF funding: €137,979.96
Funding rate: 60%

Project aims
The project aims to valorise algal biomass and promote an innovative approach to zero waste. The scientific research focuses in particular on the taste of algae with the following specific aims:

• Increase innovation in the food industry and marine technology smart specialisation sectors along the entire value chain. This improves technology transfer, especially to SMEs.
• Setting up a centre/platform of expertise that integrates all innovations and improvements (growth, processing, profiling, marketing).
• Gaining a better understanding of consumer acceptance of algae products, thereby narrowing the gap between different stakeholders (i.e. food producers and consumers).
• Gaining a better understanding of the investment required to take algae production from the pre-commercial (TRL7) to commercial (TRL9) stage (via the investor roadmap).

Expected results
The main expected result is strengthening the capacity of members of the ‘2 Seas’ region to produce reliable and consistent flows of high-quality algal biomass and process them for food, and facilitate the emergence and growth of a new sustainable food industry sector.

Other project results include

• Development of specific analysis tools and methods to help the sector assess product safety and quality, flavour profile (taste, texture, colour, aroma) and enhancers.
• The creation of an open, interdisciplinary, knowledge-based platform to support the sustainable cultivation and harvesting of algal biomass and algal-based foods that meet consumer needs.
• Drawing up a roadmap for investors.

Lead partner

• EV-ILVO - Eigen Vermogen Instituut voor Landbouw- en Visserij Onderzoek

Partners

• VITO-Vlaamse Instelling voor Technologisch Onderzoek
• HZ University of Applied Sciences
• Zeewaar BV
• University of Lille
• Marine Biological Association of the United Kingdom
• Nausicaa
• Royal Netherlands Institute for Sea Research
• Stichting Noordzeeboerderij
• ULCO - Université du Littoral Côte d'Opale
• University of Greenwich
• Texel Saline BV

Observer partners

• Flanders’ Food
• POML- Provinciale Ontwikkelingsmaatschappij West-Vlaanderen
• De Blauwe Cluster vzw
• Provincie Zeeland
• European Biogas Association
• Provincie Noord-Holland
• Aquimer
• Unilever
• Koninklijke Euroma B.V.
• WWF - World Wide Fund For Nature
• Rijkswaterstaat Zee en Delta, Ministerie van Infrastructuur en Waterstaat; Rijkswaterstaat

Contact: Sami Souissi (LOG), scientific director for the university: sami.souissi[at]univ-lille[point]fr

Website

Start date: 01/01/2020
End date: 31/03/2023

Funding
Total project budget: €4,885,142.70
Amount of ERDF funding: €2,931,085.62
Funding rate: 60%

Aim
The aim of this project is to develop innovative drug products, which are able to control the resulting drug distribution in the patient’s body: The drug amount at the site of action is to be optimised, and the amount that is ‘lost’ into the rest of the human body is to be minimised. This is to be achieved by ‘site-specific delivery systems’, which release the drug at a controlled rate at the site of action. Thus, the therapeutic efficacy will be improved & undesired side effects reduced. This will help reducing the current cost burden on our healthcare systems due to adverse drug effects. Specifically, the project aims at developing innovative site-specific drug delivery systems for the colon, inner ear, peritoneal cavity and breast.

Expected results

• Novel drug products for a safer and more efficient treatment of patients suffering from: Crohn’s disease and ulcerative colitis, Ovarian cancer with metastases in the peritoneal cavity, Breast resection due to cancer, Hearing loss/deafness.
• A novel in vitro characterisation method facilitating the development of ‘colon targeting systems’ and assuring adequate quality control during production.
• A feasibility study demonstrating the performance of the newly developed drug delivery systems.

Consortium partners

• University of Lille (Lead partner, Prof. Siepmann)
• University of Cambridge (Prof. Zeitler)
• Ghent University (Prof. Vervaet)
• University College London (Prof. Basit)
• Leiden University (Prof. Jiskoot)
• Delft University of Technology (Prof. Zadpoor)
• Lille University Hospital (Mrs. Leal)
• Lattice Medical (Dr Payen)
• Prodigest (Dr Marzorati)
• Technological Transfer Office North of France (Mr Beitone)

Observer Partners

• Addenbrooke’s Hospital
• Dr. Reddy’s Research & Development B.V.
• Eurasanté
• FabRx
• Intract Pharma
• Medtronic
• Oticon Medical
• Pfizer
• The Queen Elizabeth The Queen Mother Hospital
• Vesale Pharma

Contact: Florence Siepmann (ADDS) - florence.siepmann[at]univ-lille[point]fr

Website

Start date: 01/03/2020
End date: 30/09/2022

Funding
Total project budget: €5,449,833
Amount of ERDF funding: €214,695.39
Funding rate: 60%

Aims
This project helps companies to estimate the corrosion risk for steel immersed in water by measuring environmental markers. Our aim is to promote prevention and raise companies’ awareness of the impact of corrosion.

The aim of this project is to improve companies’ monitoring and knowledge of the risks of corrosion of their structures that are in contact with seawater, so that they can implement appropriate preventive solutions.

Expected results
Various in-situ sensors will be studied and tested in order to determine a correlation between the results provided by these sensors and the corrosion resistance or corrosion risk of steels. We will then implement and demonstrate the use of different sensors for several industrial cases (offshore wind turbines, desalination/water purification systems, ship hulls and ballast tanks, port structures, etc.). In order to present data to users in terms of corrosion risk, we will implement the use of statistical analysis by developing a data management tool.

Partners

• Antwerp Maritime Academy (AMA)
• Ghent University
• Catholic University of Leuven
• Southend Borough Council
• Sirris
• IT and Business Analytics
• University of Brighton
• Genicap Beheer BV
• University of Kent
• Cobalt Water EU BVBA
• University of Artois
• Research Centre for the Application of Steel (OCAS N.V.)
• Université Polytechnique Hauts-de-France
• INRAE
• University of Lille

Contact:

• Coordinator: Antwerp Maritime Academy (AMA) - Geert Potters: geert.potters[at]hzs[point]be
• Scientific director at the University of Lille - David Balloy (UMET): david.balloy[at]univ-lille[point]fr

Website

Start date: 01/01/2019
End date: 30/06/2022

Funding
Total project budget: €4,154,144.57
Amount of ERDF funding: €409,942.35
Funding rate: 60%

Aims
This project aims to develop and support the growth of an emerging ecosystem of connected port solutions through data science and IoT technologies. Bottom-up initiatives are forming around this common objective, mainly among those involved in port logistics, port authorities and major IT suppliers. The current aim is also to develop a community of entrepreneurs (start-ups and SMEs) and experts in data science for maritime activities. In addition, the project aims to harness the full commercial potential of start-ups and SMEs, professionalise their business activities and boost their overall (international) performance.

Expected results
The project has three main outcomes:

1. Structuring a network of start-ups, regional high-tech SMEs, experts, seaports and universities to support European ports in the ‘2 Seas’ zone in the field of data science.
2. Establishing a common approach to facilitate the development of data science applications for port logistics issues, supporting Western European ports and port stakeholders who benefit from better adoption of these new technologies.
3. Establishing a common approach to developing and improving technical value creation. This includes marketing capabilities, the professionalisation of port entrepreneurs and the adoption of intelligent port solutions for the benefit of start-ups, SMEs and users of port applications.

Partners

• Lead partner: Antwerp Management School
• University of Lille
• Stichting Katholieke Universiteit Brabant
• WSX Enterprise
• University of Bournemouth
• Portsmouth City Council
• Nxtport
• CITC-EuraRFID Centre d'innovations des technologies sans contact
• Haven van Moerdijk
• Startups.be
• Poole Harbours Commissioners
• Portland Port Limited
• Borough of Poole

Contact: Rochdi Merzouki (Cristal) - rochdi.merzouki[at]univ-lille[point]fr

Website